PROGNOSTIC VALUE OF ADDITIONAL CHROMOSOMAL ABERRATIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON TYROSINEKINASE INHIBITORS THERAPY
Prognostic significance of additional chromosomal abnormalities (ACAs) for tyrosinekinase inhibitors therapy (TKI) response in chronic myeloid leukemia (CML) patients is discussed. In many ways, this uncertainty is dueto the low frequency as well as the high variability of ACAs in patients with chro...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Ukrainian Medical Stomatological Academy
2019-04-01
|
Series: | Вісник проблем біології і медицини |
Subjects: | |
Online Access: | https://vpbm.com.ua/upload/2019-2-1/51-min.pdf |